【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 14
2 Introduction 15
2.1 Spinal Non-Fusion Overview 15
3 Products under Development 16
3.1 Spinal Non-Fusion – Pipeline Products by Stage of Development 16
3.2 Spinal Non-Fusion – Pipeline Products by Segment 17
3.3 Spinal Non-Fusion – Pipeline Products by Territory 18
3.4 Spinal Non-Fusion – Pipeline Products by Regulatory Path 19
3.5 Spinal Non-Fusion – Pipeline Products by Estimated Approval Date 20
3.6 Spinal Non-Fusion – Ongoing Clinical Trials 21
4 Spinal Non-Fusion – Pipeline Products under Development by Companies 22
4.1 Spinal Non-Fusion Companies – Pipeline Products by Stage of Development 22
4.2 Spinal Non-Fusion – Pipeline Products by Stage of Development 25
5 Spinal Non-Fusion Companies and Product Overview 28
5.1 ALCeraX Medizintechnik GmbH Company Overview 28
5.1.1 ALCeraX Medizintechnik GmbH Pipeline Products & Ongoing Clinical Trials Overview 28
5.2 Alphatec Holdings, Inc. Company Overview 29
5.2.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 Amedica Corporation Company Overview 32
5.3.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 32
5.4 Apollo Implants LLC Company Overview 35
5.4.1 Apollo Implants LLC Pipeline Products & Ongoing Clinical Trials Overview 35
5.5 ARO Medical, LLC Company Overview 36
5.5.1 ARO Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.6 Arthro Kinetics AG Company Overview 37
5.6.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 37
5.7 Artimplant AB Company Overview 38
5.7.1 Artimplant AB Pipeline Products & Ongoing Clinical Trials Overview 38
5.8 Ascendx Spine, Inc. Company Overview 42
5.8.1 Ascendx Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 AxioMed Spine Corporation Company Overview 43
5.9.1 AxioMed Spine Corporation Pipeline Products & Ongoing Clinical Trials Overview 43
5.10 Baxano Surgical Inc Company Overview 48
5.10.1 Baxano Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 Chi2Gel Ltd. Company Overview 52
5.11.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 52
5.12 City University London Company Overview 53
5.12.1 City University London Pipeline Products & Ongoing Clinical Trials Overview 53
5.13 Covexus Medical Technologies, LLC Company Overview 54
5.13.1 Covexus Medical Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 54
5.14 Crocker Spinal Technologies, Inc. Company Overview 55
5.14.1 Crocker Spinal Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 CryoLife, Inc. Company Overview 57
5.15.1 CryoLife, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 Curtin University Company Overview 59
5.16.1 Curtin University Pipeline Products & Ongoing Clinical Trials Overview 59
5.17 DePuy Companies Company Overview 60
5.17.1 DePuy Companies Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 Disc Motion Technologies Company Overview 64
5.18.1 Disc Motion Technologies Pipeline Products & Ongoing Clinical Trials Overview 64
5.19 Elite Surgical Supplies (Pty) Limited Company Overview 68
5.19.1 Elite Surgical Supplies (Pty) Limited Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 FlexSIS Ltd. Company Overview 69
5.20.1 FlexSIS Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
5.21 Flexuspine, Inc. Company Overview 70
5.21.1 Flexuspine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
5.22 Gentis Inc. Company Overview 71
5.22.1 Gentis Inc. Pipeline Products & Ongoing Clinical Trials Overview 71
5.23 Globus Medical, Inc. Company Overview 74
5.23.1 Globus Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
5.24 Hydrospine, Inc. Company Overview 81
5.24.1 Hydrospine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 IB Medical AB Company Overview 82
5.25.1 IB Medical AB Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 Innovia LLC Company Overview 83
5.26.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.27 Integra LifeSciences Holdings Corporation Company Overview 84
5.27.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 84
5.28 Jemo Spine, LLC. Company Overview 86
5.28.1 Jemo Spine, LLC. Pipeline Products & Ongoing Clinical Trials Overview 86
5.29 LDR Holding Corporation Company Overview 87
5.29.1 LDR Holding Corporation Pipeline Products & Ongoing Clinical Trials Overview 87
5.30 Medical University of South Carolina Company Overview 89
5.30.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 89
5.31 Medicrea International SA Company Overview 90
5.31.1 Medicrea International SA Pipeline Products & Ongoing Clinical Trials Overview 90
5.32 Medtronic plc Company Overview 95
5.32.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 95
5.33 MI4 Spine, LLC Company Overview 100
5.33.1 MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 100
5.34 MicroPort Scientific Corporation Company Overview 101
5.34.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 101
5.35 MiMedx Group, Inc Company Overview 103
5.35.1 MiMedx Group, Inc Pipeline Products & Ongoing Clinical Trials Overview 103
5.36 Nano Interface Technology, Inc. Company Overview 105
5.36.1 Nano Interface Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105
5.37 NeuroPro Technologies, Inc. Company Overview 106
5.37.1 NeuroPro Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 106
5.38 Nexgen Spine Inc. Company Overview 107
5.38.1 Nexgen Spine Inc. Pipeline Products & Ongoing Clinical Trials Overview 107
5.39 NLT Spine Company Overview 109
5.39.1 NLT Spine Pipeline Products & Ongoing Clinical Trials Overview 109
5.40 NuVasive, Inc. Company Overview 113
5.40.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.41 Orthonex LLC Company Overview 119
5.41.1 Orthonex LLC Pipeline Products & Ongoing Clinical Trials Overview 119
5.42 Paramount Surgicals Company Overview 122
5.42.1 Paramount Surgicals Pipeline Products & Ongoing Clinical Trials Overview 122
5.43 Precision Spine, Inc. Company Overview 125
5.43.1 Precision Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 125
5.44 Premia Spine, Ltd. Company Overview 126
5.44.1 Premia Spine, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 126
5.45 Ranier Technology Limited Company Overview 129
5.45.1 Ranier Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Raymedica, LLC Company Overview 132
5.46.1 Raymedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 132
5.47 RE Spine, LLC Company Overview 134
5.47.1 RE Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 134
5.48 Reduction Technologies, Inc. Company Overview 135
5.48.1 Reduction Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.49 Replication Medical, Inc. Company Overview 136
5.49.1 Replication Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 136
5.50 Resoimplant GmbH (Inactive) Company Overview 137
5.50.1 Resoimplant GmbH (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 137
5.51 S14 Implants Company Overview 138
5.51.1 S14 Implants Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 SeaSpine, Inc. (Inactive) Company Overview 139
5.52.1 SeaSpine, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 139
5.53 Simpirica Spine, Inc. Company Overview 140
5.53.1 Simpirica Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 140
5.54 Simplify Medical, Inc. Company Overview 142
5.54.1 Simplify Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 142
5.55 Smart Disc, Inc. Company Overview 143
5.55.1 Smart Disc, Inc. Pipeline Products & Ongoing Clinical Trials Overview 143
5.56 Spinal Kinetics Inc. Company Overview 144
5.56.1 Spinal Kinetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.57 Spinalcyte Llc Company Overview 149
5.57.1 Spinalcyte Llc Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 SpinalMotion, Inc. Company Overview 150
5.58.1 SpinalMotion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 SpinalVu Inc Company Overview 157
5.59.1 SpinalVu Inc Pipeline Products & Ongoing Clinical Trials Overview 157
5.60 Spine Smith, LP Company Overview 158
5.60.1 Spine Smith, LP Pipeline Products & Ongoing Clinical Trials Overview 158
5.61 Spine Wave, Inc. Company Overview 160
5.61.1 Spine Wave, Inc. Pipeline Products & Ongoing Clinical Trials Overview 160
5.62 Spine21 Ltd. Company Overview 163
5.62.1 Spine21 Ltd. Pipeline Products & Ongoing Clinical Trials Overview 163
5.63 SpineLab AG Company Overview 164
5.63.1 SpineLab AG Pipeline Products & Ongoing Clinical Trials Overview 164
5.64 Stryker Corporation Company Overview 165
5.64.1 Stryker Corporation Pipeline Products & Ongoing Clinical Trials Overview 165
5.65 Synergy Disc Replacement, Inc. Company Overview 167
5.65.1 Synergy Disc Replacement, Inc. Pipeline Products & Ongoing Clinical Trials Overview 167
5.66 Synthes, Inc. Company Overview 169
5.66.1 Synthes, Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.67 Takiron Co., Ltd. Company Overview 170
5.67.1 Takiron Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 170
5.68 TrueMotion Spine, Inc. Company Overview 172
5.68.1 TrueMotion Spine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 172
5.69 University of Colorado Company Overview 174
5.69.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 174
5.70 University of South Florida Company Overview 175
5.70.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 175
5.71 Vertebral Technologies, Inc. Company Overview 176
5.71.1 Vertebral Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 176
5.72 Weill Cornell Medical College Company Overview 180
5.72.1 Weill Cornell Medical College Pipeline Products & Ongoing Clinical Trials Overview 180
5.73 X-spine Systems, Inc. Company Overview 181
5.73.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.74 Zimmer Biomet Holdings, Inc. Company Overview 182
5.74.1 Zimmer Biomet Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 182
6 Spinal Non-Fusion – Recent Developments 188
7 Appendix 226
7.1 Methodology 226
7.2 About GlobalData 228
7.3 Contact Us 229
7.4 Disclaimer 229
【レポート販売概要】
■ タイトル：世界における脊椎非固定デバイスの製品パイプライン動向2015■ 英文：Spinal Non-Fusion - Pipeline Review, 2015
■ 発行日：2015年9月4日
■ 調査会社：GlobalData
■ 商品コード：GDME0066EPD
■ 調査対象地域：グローバル
- 世界のデジタルカメラ市場動向To maximize product differentiation, smartphone brands have been upgrading their camera modules for improved photo quality. Their efforts in advancing smartphone photography, however, have jeopardized the global digital camera market. This is especially detrimental to the survival of entry-level and mid-range digital cameras. For this reason, digital camera brands have been repositioning their pro …
- クラウド型VDIの世界市場：導入別（民間、公的、複合型）、最終用途別（政府、ヘルスケア、テレコム・IT、教育、その他）、地域別予測Global Cloud-based VDI Market to reach USD XXX billion by 2025. Global Cloud-based VDI Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are increase in adoption of cloud-based solutions Rise in demand for virtualization Increase in adoption of …
- 産業用スケール抑制剤の世界市場2016-2020About the Industrial Anti-Scaling Chemicals Market The global industrial anti-scaling chemicals market is driven by the increasing demand from key end-uses including the oil, gas, and mining and water and wastewater treatment industries. The rapid growth of these industries in leading regions such as APAC, Central and South America, and Africa will be a key contributing factor. Anti-scaling chemic …
- 世界のマイクロCHP（熱電併給）システム市場（2014-2018）About Micro CHP Systems A micro CHP system is about the size of a major appliance with a capacity ranging from 1 kW to 6 kW and produces electricity as well as heat using generally natural gas as fuel. Micro CHP systems are extremely efficient with combined heat and power generating efficiency of approximately 90 percent. The small engines used in a micro CHP system burn fuel cleanly, providing re …
- グリコール酸の世界市場2015Glycolic Acid (CAS 79-14-1) Market Research Report 2015 aims at providing comprehensive data on Glycolic Acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Glycolic Acid description, covers its application areas, manufacturing methods, patterns. It captures Glycolic Acid market trends, pays close attention to Glycolic Acid manufacturers and na …
- 中東・アフリカ（MENA）の継目無銅管市場2015-2019About Seamless Copper Tubes The seamless copper tubes market in MENA is highly dependent on imports from suppliers in China, the Far East (Malaysia, Thailand, and Japan), the US, and Europe as there are no major local suppliers apart from Iran. Qaem Copper in Iran is a major supplier of seamless copper tubes in the region, mainly catering to the local demand in Iran and exporting in smaller quanti …
- ロシアのエネルギー政策及びエネルギー政治：Analyzing Russia’s Energy Policy & Energy PoliticsRussia’s real gross domestic product (GDP) surpassed average growth rates in all other G8 countries in recent years, marking the country’s seventh consecutive year of economic expansion. Russia’s economic growth over the past seven years has been driven primarily by energy exports, given the increase in Russian oil production and relatively high world oil prices during the period. Internally, Russ …
- d‐リモネンの世界市場D-Limonene (CAS 5989-27-5) Market Research Report 2013 presents comprehensive data on d-limonene markets globally and regionally (Europe, Asia, North America etc.) The D-Limonene (CAS 5989-27-5) Market Research Report 2013 includes d-limonene description, covers its application areas and related patterns. It overviews d-limonene market, names d-limonene producers and indicates its suppliers. Besid …
- 原子力艦艇の世界市場2017-2021ABSTRACTAbout Nuclear Powered Naval Vessels A nuclear-powered naval vessel uses nuclear energy to power its propulsion system and is constructed with a nuclear power plant placed inside a section of the ship, which is coded as the reactor compartment. The components of the nuclear power plant include a high-strength steel reactor vessel, heat exchanger, steam generator, and associated piping, pump …
- バス用シートの世界市場予測（～2022）The bus seat market is expected to be valued at USD 10.03 Billion by 2022, growing at a CAGR of 5.2% between 2016 and 2022. This market includes bus seats for different type of buses such as transit, coach, transfer, and others. The key drivers for the growth of this market include the rising demand for comfort and luxury, growing demand for advanced transportation, and increasing vehicle producti …
- スマートウィンドウ材料の世界市場2015-2022From the perspective of materials suppliers, n-tech believes that the smart windows market continues to offer important opportunities. We are seeing older technologies – such as photochromics – become more competitive with the dominant SPD and electrochromic materials and there are also entirely new materials such as hydrogels and versioned display materials that are beginning to play in the smart …
- ミニショベル（ミニエクスカベーター）の世界市場About Mini Excavators Mini excavators, also commonly known as compact excavators, are tracked or wheeled vehicles. They weigh approximately around 0.7 to 8.5 tons. With their compact size, mini excavators can fit through doorways and can even be used for carrying out work at mining sites. TechNavio's analysts forecast the Global Mini Excavators Market to grow at a CAGR of 9.34 percent over the per …
- 殺鼠剤（ねずみ駆除剤）のグローバル市場Report Description The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in integrated pest management programs. The emerging markets with increasing demand for rodenticides are estimated to generate potential opportunities in the market. The rodenticides market was sub-segmen …
- 2014年戦略提言：ドイツの血液及びフローサイトメトリー市場Complete report $6,200. DataPack (test volumes, sales forecasts, supplier shares) $3,900.SummaryThis comprehensive report contains 250 pages, 32 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in German hematology and flow cytometry markets during the next five years. The report explores business and …
- Micromed S.p.A：市場シェア分析Micromed S.p.A Market Share Analysis Summary GlobalData’s new report, “Micromed S.p.A Market Share Analysis” provides in-depth information on Micromed S.p.A’s market position in the neurological diagnostic equipments market. The report also provides data and information on the overall competitive landscape within the neurological diagnostic equipments market. The report is supplemented with global …
